Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452374
Status:
COMPLETED
Last Update Posted:
2011-11-02
First Post:
2007-03-23
Brief Title:
Oxaliplatin Fludarabine Cytarabine and Rituximab in Richters Syndrome Refractory CLL and PLL
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
Keywords:
| Name | View |
|---|---|
| Rituxan | View |
| B-cell chronic lymphocytic leukemia | View |
| Chronic Lymphocytic Leukemia | View |
| CLL | View |
| Prolymphocytic Leukemia | View |
| PLL | View |
| Richters Transformation | View |
| High-grade non-Hodgkins lymphoma | View |
| Hodgkins disease | View |
| Acute leukemia | View |
| Small lymphocytic lymphoma | View |
| Oxaliplatin | View |
| Eloxatin | View |
| Fludarabine | View |
| Cytarabine | View |
| Ara-C | View |
| Cytosar | View |
| DepoCyt | View |
| Cytosine arabinosine hydrochloride | View |
| Rituximab | View |